drugset / Trial / NCT01553617

VolulyteTM in Cardiac Surgery

NCT01553617

Phase 4 Completed 133 enrolled Fresenius Kabi
RandomizedParallel-groupOpen-labelTreatment

Summary

The study will compare the efficacy and safety of VolulyteTM and human albumin in elective open-heart surgery in adult patients.

Timeline

Start
2012-10
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Human serum albumin Protein / enzyme biologic
Subject Volulyte Other / unclassified